Indirect resellers seek final approval for settlement with Apotex in US generic drug suit
MLex Summary: Indirect resellers asked a US federal judge to grant final approval to their $5.2 million settlement with Apotex to resolve US price-fixing claims over generic pharmaceuticals. See attached file. ...To view the full article, register now.
Already a subscriber? Click here to view full article